Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 12.88
-0.28 (-2.13%)
Jul 10, 2026, 4:08 PM HKT
Xuanzhu Biopharmaceutical Market Cap
Xuanzhu Biopharmaceutical has a market cap or net worth of 6.67 billion as of July 10, 2026.
Market Cap
6.67B
Enterprise Value
5.95B
Revenue
57.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.88
Market Cap Chart
Since October 15, 2025, Xuanzhu Biopharmaceutical's market cap has decreased from 13.62B to 6.67B, a decrease of -51.03%. That is a compound annual growth rate of -62.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 6.67B | -81.73% |
| Dec 31, 2025 | 36.52B | 168.06% |
| Oct 15, 2025 | 13.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CanSino Biologics | 9.89B |
| Shandong Xinhua Pharmaceutical Company | 9.46B |
| Luye Pharma Group | 7.67B |
| Sihuan Pharmaceutical Holdings Group | 7.67B |
| China Traditional Chinese Medicine Holdings Co. | 7.20B |
| CF PharmTech | 7.19B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 7.17B |
| SSY Group | 6.74B |